42 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Unknown  Shiga Progression of Diabetes, Nephropathy and Retinopathy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone add on to SU or biguanide;   Drug: SU or Biguanide
22 Unknown  Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active  titration algorithm;   Behavioral: Usual titration algorithm
23 Unknown  Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Risk;   Endothelial Dysfunction
Intervention:
24 Recruiting Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II
Condition: Diabetes Mellitus Type II
Intervention: Drug: e.-coli-nissle
25 Recruiting COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy
Conditions: Diabetes;   Endocrine, Nutritional and Metabolic Diseases (E00-E89)
Intervention: Device: Metabolic Neuromodulation System (MNS)
26 Recruiting The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia
Conditions: Type 1 Diabetes Mellitus;   Hypoglycemia Unawareness
Interventions: Behavioral: High intensity exercise;   Behavioral: Lay down comfortably
27 Unknown  Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial
Condition: Type 2 Diabetes Mellitus
Interventions: Device: Tantalus;   Drug: Insulin
28 Recruiting Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator
Condition: Hypoglycemia
Interventions: Drug: ZP4207;   Drug: Glucagon
29 Recruiting The Hellenic Postprandial Lipemia Study (HPLS)
Conditions: Coronary Heart Disease;   Dyslipidemia
Intervention:
30 Unknown  The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1
Condition: Pharmacogenetics of Metformin
Intervention: Drug: Metformin
31 Unknown  Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
32 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
Conditions: Peripheral Arterial Disease;   Intermittent Claudication
Interventions: Drug: Metformin;   Drug: Placebo
33 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
34 Unknown  Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Drug: Tadalafil
35 Recruiting Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Welchol for oral suspension placebo proxy;   Drug: Welchol for oral suspension
36 Unknown  An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects
Conditions: Hyperglycemia;   Diabetes
Intervention:
37 Recruiting Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Liraglutide;   Drug: Placebo;   Drug: Mixed Meal Tolerance Test with paracetamol
38 Unknown  Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD)
Condition: Diabetes Type 2
Intervention: Other: High Dialysate bath
39 Recruiting A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2;   Albuminuria
Interventions: Drug: Placebo;   Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg
40 Recruiting DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings
Condition: Type 2 Diabetes Mellitus
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years